Murray-Jobsis J
University of North Carolina.
Am J Clin Hypn. 1991 Jan;33(3):150-60; discussion 161-71. doi: 10.1080/00029157.1991.10402925.
A review of current clinical and experimental research discloses that psychotic patients display hypnotic capacity. There is disagreement about the degree of this capacity. The most recent research indicates that schizophrenic populations are comparable to normal populations on the Stanford Scales of Hypnotic Susceptibility and the Harvard Group Scale of Hypnotic Susceptibility. However, on the Hypnotic Induction Profile the mean scores of schizophrenics are significantly lower than normals. To investigate these inconsistencies, I undertook and exploratory study of the hypnotizability of schizophrenic and borderline patients in a clinical setting. Test results in this clinical setting, using the Stanford Scale of Hypnotic Susceptibility: Form A and the Hypnotic Induction Profile, indicated higher than usual hypnotizability. The effects of transference in the clinical setting may be a possible explanation for some of the differences in the test results. Posttest questioning revealed response patterns and conflicts that may be unique to the severely disturbed patient population. These response patterns may influence the test norms for this population and may further help explain differences in findings.
对当前临床和实验研究的回顾表明，精神病患者具有催眠能力。对于这种能力的程度存在分歧。最新研究表明，在斯坦福催眠易感性量表和哈佛催眠易感性团体量表上，精神分裂症患者群体与正常人群相当。然而，在催眠诱导剖面图上，精神分裂症患者的平均得分显著低于正常人。为了研究这些不一致之处，我在临床环境中对精神分裂症患者和边缘性人格障碍患者的催眠能力进行了一项探索性研究。在该临床环境中，使用斯坦福催眠易感性量表A版和催眠诱导剖面图进行测试的结果表明，催眠能力高于平常。临床环境中移情的影响可能是测试结果存在一些差异的一个可能解释。测试后询问揭示了可能是严重精神障碍患者群体所特有的反应模式和冲突。这些反应模式可能会影响该群体的测试标准，并可能进一步有助于解释研究结果的差异。
